CD8-positive Lymphocytes in Graft-Versus-Host Disease of Humanized NOD

被引:6
|
作者
Laing, S. T. [1 ]
Griffey, S. M. [1 ]
Moreno, M. E. [2 ]
Stoddart, C. A. [2 ]
机构
[1] Univ Calif Davis, Comparat Pathol Lab, Davis, CA 95616 USA
[2] Univ Calif San Francisco, San Francisco Gen Hosp, Div Expt Med, San Francisco, CA USA
关键词
CD8; lymphocytes; graft-versus-host disease; NSG-hu-BLT mice; T-CELLS; MICE; MOUSE; MODEL; ALLOSUPPRESSOR; ENGRAFTMENT;
D O I
10.1016/j.jcpa.2014.12.010
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Immunocompromised mice that can support a human immune system are an increasingly important model for the investigation of haemopoietic stem/progenitor cell (HSPC) development and human infectious disease. NOD-SCID IL-2R gamma(-/-) (NSG) mice engrafted with human fetal liver and thymus prior to HSPC engraftment, commonly known as NSG bone marrow liver thymus (NSG-hu-BLT) mice, are one such model and have robust reconstitution of human leucocytes within the peripheral blood and tissues. Four NSG-hu-BLT mice were submitted for diagnostic necropsy examination following the development of alopecia, pruritus and lethargy after HSPC engraftment. Histopathology revealed multifocal to coalescing single keratinocyte cell death in the epidermis and follicles with dermatitis and mild dermal fibrosis. Single-cell hepatocyte cell death was present in three cases, with various degrees of portal fibrosis. In the skin and liver, cell death was associated with lymphocytes that reacted with anti-human CD45, CD3 and CD8 antibodies, consistent with a diagnosis of graft-versus-host disease (GvHD). This study expands on recently reported microscopical features of GvHD in NSG-hu-BLT mice and suggests a role for CD8(+) T lymphocytes in the progression of the disease. NSG-hu-BLT mice represent an excellent model of GvHD, but its prevalence may compromise their use in other fields of biomedical research. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:238 / 242
页数:5
相关论文
共 50 条
  • [21] GRAFT-VERSUS-HOST DISEASE OR GRAFT-VERSUS-HOST LIKE SYNDROME - RESPONSE
    YEAGER, AM
    BLOOD, 1992, 80 (11) : 2949 - 2950
  • [22] Immunomodulatory Effect of IVIG in a Humanized Mouse Model of Graft-versus-host Disease
    Gregoire-Gauthier, Joelle
    Fontaine, Francois
    Duval, Arnaud
    Durrieu, Ludovic
    Dieng, Mame Massar
    de Serre, Natalie Patey-Mariaud
    Le Deist, Francoise
    Haddad, Elie
    CLINICAL IMMUNOLOGY, 2010, 135 : S92 - S92
  • [23] GRAFT-VERSUS-HOST DISEASE
    KODO, H
    ACTA HAEMATOLOGICA JAPONICA, 1987, 50 (08): : 1621 - 1626
  • [24] Graft-versus-host disease
    Moreno, David F.
    Cid, Joan
    MEDICINA CLINICA, 2019, 152 (01): : 22 - 28
  • [25] Graft-versus-host disease
    Warren D. Shlomchik
    Nature Reviews Immunology, 2007, 7 : 340 - 352
  • [26] GRAFT-VERSUS-HOST DISEASE
    KAITIN, KI
    NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (05): : 357 - 358
  • [27] GRAFT-VERSUS-HOST DISEASE
    GALE, RP
    IMMUNOLOGICAL REVIEWS, 1985, 88 : 193 - 214
  • [28] Graft-versus-host disease
    Ferrara, James L. M.
    Levine, John E.
    Reddy, Pavan
    Holler, Ernst
    LANCET, 2009, 373 (9674): : 1550 - 1561
  • [29] GRAFT-VERSUS-HOST DISEASE
    PARKMAN, R
    ANNUAL REVIEW OF MEDICINE, 1991, 42 : 189 - 197
  • [30] GRAFT-VERSUS-HOST DISEASE
    FERRARA, JLM
    DEEG, HJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (10): : 667 - 674